Omnicell's first-quarter GAAP revenue up 4% to $54.2M

Omnicell, Inc. (Nasdaq: OMCL), a leading global provider of system solutions to acute healthcare facilities, today announced results for its first quarter ended March 31, 2010.

GAAP results: Revenue for the first quarter of 2010 was $54.2 million, down $0.5 million or 1% from the fourth quarter of 2009, and up $2.0 million or 4% from the first quarter of 2009.

First quarter 2010 net income as reported in accordance with U.S. generally accepted accounting principles (GAAP) was $1.0 million, or $0.03 per diluted share. This compares to net income of $0.6 million, or $0.02 per diluted share in the fourth quarter of 2009, and a net loss of $1.9 million, or $0.06 per diluted share in the first quarter of 2009 which included one-time restructuring charges totaling $1.5 million, net of tax.

Non-GAAP results: Non-GAAP net income was $3.1 million for the first quarter of 2010, or $0.09 per diluted share, which excludes $2.2 million in stock compensation expense. This compares to non-GAAP net income of $3.4 million, or $0.11 per diluted share for the fourth quarter of 2009, which excludes both $2.5 million in stock compensation expense and $0.4 million in non-recurring tax adjustments.  First quarter 2010 results compare to non-GAAP net income of $2.1 million, or $0.07 per diluted share for the first quarter of 2009, which excludes both $2.5 million in stock compensation expense and $1.5 million net of tax restructuring charges.

"I am pleased with our performance and results in the first quarter of 2010," said Randall Lipps, Omnicell President, Chairman and CEO. "Both domestically and internationally, our solutions continue to resonate with new and existing hospital customers who are seeking a trustworthy partner and expert advisor for adding the safest and most effective medication and supply automation capabilities to their operations."

Source:

Omnicell, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Omnicell, Inc.. (2019, June 19). Omnicell's first-quarter GAAP revenue up 4% to $54.2M. News-Medical. Retrieved on December 02, 2021 from https://www.news-medical.net/news/20100427/Omnicells-first-quarter-GAAP-revenue-up-425-to-24542M.aspx.

  • MLA

    Omnicell, Inc.. "Omnicell's first-quarter GAAP revenue up 4% to $54.2M". News-Medical. 02 December 2021. <https://www.news-medical.net/news/20100427/Omnicells-first-quarter-GAAP-revenue-up-425-to-24542M.aspx>.

  • Chicago

    Omnicell, Inc.. "Omnicell's first-quarter GAAP revenue up 4% to $54.2M". News-Medical. https://www.news-medical.net/news/20100427/Omnicells-first-quarter-GAAP-revenue-up-425-to-24542M.aspx. (accessed December 02, 2021).

  • Harvard

    Omnicell, Inc.. 2019. Omnicell's first-quarter GAAP revenue up 4% to $54.2M. News-Medical, viewed 02 December 2021, https://www.news-medical.net/news/20100427/Omnicells-first-quarter-GAAP-revenue-up-425-to-24542M.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Omnicell's revenue increases 11.0% to $125.2 million in Q3 2015